IRVINE, Calif., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN), a patient-focused clinical stage biopharmaceutical company committed to the development of innovative and impactful treatments for organ and cell transplantation, autoimmune conditions, and neurodegenerative disease, today announced that the U.S. Food and Drug Administration (FDA) has… Read More..

faidr Listening Experience Displays Significant Improvement with Percentage of Stations Using the Advanced AI Algorithm Increasing from 10% to 88% On Track to Apply Advanced AI to Remaining 12% of Stations by End of Q3 BOULDER, CO / ACCESSWIRE / August 1, 2022 / Auddia Inc. (NASDAQ:AUUD) (NASDAQ:AUUDW) ("Auddia" or… Read More..

EMA Guidance Provides Clear Path Forward for Quoin’s Netherton Syndrome Product in Europe ASHBURN, Va., July 28, 2022 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, announces that it has received comprehensive and constructive… Read More..